The Middle East and Africa Cancer Hormone Therapy Market is supported by expanding oncology services, improved screening capabilities, and greater emphasis on early cancer diagnosis. The Middle East and Africa cancer hormone therapy market size is expected to reach US$ 1,468.2 million by 2031 from US$ 841.3 million in 2024. The market is estimated to record a CAGR of 8.3% from 2025 to 2031....